يعرض 1 - 10 نتائج من 350 نتيجة بحث عن '"Savelius, A"', وقت الاستعلام: 1.06s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    كتاب

    المساهمون: Martin, Marjatta, Soronen, Kari

    المصدر: Nordling , E , Kivistö , M , Martin , M , Rissanen , P , Savelius-Koski , E & Soronen , K 2022 , Mielenterveys- ja päihdepalvelujen asiakaslähtöisyys terveydenhuollon järjestämissuunnitelmissa . julkaisussa M Martin & K Soronen (toim) , Toipumisorientaatio mielenterveyspalveluissa . Lapin yliopisto , Lapin yliopiston yhteiskuntatieteellisiä julkaisuja. Sarja C. Työpapereita , Nro 8 , Sivut 123-139 . < https://urn.fi/URN:ISBN:978-952-337-321-1Test >

  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية

    المساهمون: CAN-PRO - Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, HUS Comprehensive Cancer Center

    وصف الملف: application/pdf

    العلاقة: This work was supported by the US National Institutes of Health 1R01CA223817 (A.G.), F32CA243548 (J.V.L.), T32CA108462 (to J.V.L.); the CDMRP Breast Cancer Research Program W81XWH-16-1-0603 (A.G.) and W81XWH-21-1-0774 (A.G., J.K.); the Breast Cancer Research Foundation (H.S.R.); METAvivor Research Award (A.G.); The Mark Foundation Endeavor Awards (A.G.); The Gazarian Family Endowment (A.G.) and the National Science Foundation #1650113 (to R.N.). We acknowledge the PFCC (RRID:SCR_018206) for assistance generating flow cytometry data. Research reported here was supported in part by the DRC Center Grant NIH P30 DK063720. We thank all of the patients who volunteered to participate in the I-SPY 2 TRIAL.; Lee , J , Housley , F , Yau , C , Nakagawa , R , Winkler , J , Anttila , J M , Munne , P M , Savelius , M , Houlahan , K E , Van de Mark , D , Hemmati , G , Hernandez , G A , Zhang , Y , Samson , S , Baas , C , Esserman , L J , van 't Veer , L J , Rugo , H S , Curtis , C , Klefström , J , Matloubian , M & Goga , A 2022 , ' Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer ' , Nature Communications , vol. 13 , no. 1 , 3671 . https://doi.org/10.1038/s41467-022-31238-yTest; ORCID: /0000-0002-9720-9964/work/156645869; http://hdl.handle.net/10138/346480Test; f07047aa-7774-4b3d-9e9b-95717a63619d; 000818961600008

  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المساهمون: Translational Cancer Biology (TCB) Research Programme, Research Programs Unit, University of Helsinki, Medicum, CAN-PRO - Translational Cancer Medicine Program, Integrins in immunity, Department of Clinical Chemistry and Hematology, Clinicum, Department of Oncology, Centre of Excellence in Stem Cell Metabolism, Timo Pyry Juhani Otonkoski / Principal Investigator, Research Programme for Molecular Neurology, Juha Klefström / Principal Investigator, Biosciences, Institute of Biotechnology, STEMM - Stem Cells and Metabolism Research Program, Institute for Molecular Medicine Finland, Tero Aittokallio / Principal Investigator, Department of Pathology, II kirurgian klinikka, Department of Surgery, Heikki Joensuu / Principal Investigator, Hematologian yksikkö, HUSLAB, HUS Children and Adolescents, HUS Comprehensive Cancer Center

    وصف الملف: application/pdf

    العلاقة: We thank Biomedicum Functional Genomics Unit (FuGu), Biomedicum Imaging Unit (BIU), University of Helsinki Language services, and Biomedicum FACS Core for services, Tarja Valimaki and Maiju Merisalo-Soikkeli for technical support, Prof. Kari Alitalo and Pauliina Kallio (University of Helsinki) for providing advice and reagents for mouse experiments, Anne Lehtonen (AbbVie Oy) for commenting the manuscript, and Johanna Englund for help with the experiments. This work was funded by the Academy of Finland, TEKES and the Finnish Cancer Organizations; H.M.H. was funded by the Integrative Life Sciences Doctoral Program (ILS), DSHealth doctoral school, Biomedicum Helsinki Foundation, Orion-Farmos Foundation, Emil Aaltonen Foundation, and the Inkeri & Mauri Vanska Foundation. S.M. and M.I. were funded by the Finnish Cancer Institute, Sigrid Juselius Foundation, Finnish special governmental subsidy for health sciences, research, and training (EVO-funding).; Haikala , H M , Anttila , J M , Marques , E , Raatikainen , T , Ilander , M , Hakanen , H , Ala-Hongisto , H , Savelius , M , Balboa , D , Von Eyss , B , Eskelinen , V , Munne , P , Nieminen , A I , Otonkoski , T , Schüler , J , Laajala , T D , Aittokallio , T , Sihto , H , Mattson , J , Heikkilä , P , Leidenius , M , Joensuu , H , Mustjoki , S , Kovanen , P , Eilers , M , Leverson , J D & Klefström , J 2019 , ' Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy ' , Nature Communications , vol. 10 , 620 . https://doi.org/10.1038/s41467-019-08541-2Test; ORCID: /0000-0003-0281-2507/work/55348826; ORCID: /0000-0002-0886-9769/work/55352310; ORCID: /0000-0002-0816-8241/work/55353373; ORCID: /0000-0003-0249-3374/work/63350527; ORCID: /0000-0001-5265-5509/work/116550031; ORCID: /0000-0001-8999-6040/work/147391055; ORCID: /0000-0002-9720-9964/work/156645864; http://hdl.handle.net/10138/300047Test; 8a475917-513b-45d5-bcfd-f32c4654305d; 85061155012; 000457862200005

  8. 8
  9. 9
  10. 10
    دورية أكاديمية